A love of GameStop (GME), SPACs, and IPOs is matched with disdain for US stocks in general this week. Dividends are supposed to make a comeback in 2021, with GDP growth and an end to COVID.
A recent fintech IPO sets up for a huge move. Analysts are finally turning on to the story.
A high flying medical diagnostics company has investors scared of falling revenue after COVID vaccines become available. The reaction was a strong sell off and now the stock is back on track towards its all time highs.
We review the US Democratic sweep as it applies to the sectors responding to more stimulus, regulation and COVID vaccines. Morgan Stanley and Citibank like airlines, including Southwest Airlines, GOL Linhas, and British Air Group.
Small cap stock picks continue to perform well, even as markets become more overbought.
A timely play in a company focused on autoimmune disease detection for diseases disproportionately affecting women.
A rally in underperforming small cap stocks is likely during January. We highlight a few names of interest here.
With more than 25% short interest, this $40 Billion US mortgage provider could be heading for a 25% gain in coming months.
If Hawaiian tourism picks up after COVID, this banking stock could continue to rebound from its post COVID lows. Technically, the chart is set up for a major break out.
With continued support for US infrastructure spending and increasing demand for broadband access in rural areas, this stock is poised to experience growth in 2021.
Fund Managers returns in November impress. Sector investing through a value/growth lens when the two opposites are not so clearly divided. Markets showing signs of rolling over. A ‘No Deal’ Brexit looks more certain.